Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
ShangPharma
ShangPharma
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Scleroderma treatment by Certa Therapeutics granted US FDA fast track
FT011 is a novel, first-in-class oral therapy for the treatment of chronic fibrosis in multiple organs
Naobios and Sumagen sign exclusive partnership to develop HIV vaccine
Naobios will manage process development and initiate launch of cGMP manufacturing for phase II clinical trials
Rapid increase in purchasing teams expected at CPHI North America
Macro-uncertainty and large CDMO acquisitions attributed to have driven a surge in R&D, purchasing and QC/QA attendees at event
Bio-Rad and Oncocyte partner to commercialise transplant monitoring with Droplet Digital PCR
The collaboration aims to provide researchers with tools to enable transformational monitoring of key biomarkers in solid tissue transplants
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Design & Build
ShangPharma and Qidong Biopharma sign US$60m investment deal in China
Preclinical research facility and a state-of-the-art biologics manufacturing facility to be built in Qidong
Manufacturing
Mitchell Reff becomes Chief Biologics Officer at ShangPharma
He brings more than 30 years of reaearch experience to the position
Manufacturing
ShangPharma appoints Arthur Taveras as President and CSO
Taveras brings the experience of a 24-year career to the Chinese contract research organisation
Buyouts prove popular in China
Chinese pharma companies turning to private capital
You need to be a subscriber to read this article.
Click here
to find out more.
Finance
Picking up a good deal
This month Asia correspondent A Nair looks at why the emerging economies provide so many tempting takeover targets for Big Pharma
Research & Development
ShangPharma opens new plant to support Eli Lilly
Also signs a multi-year extension of its contract with the US firm
Subscribe now